XBI ETF

$130.65
Screen 3,400+ ETFsFind similar ETFs with lower fees

Returns Overview

1 Month
+2.14%
3 Months
+3.79%
6 Months
+42.27%
YTD
+4.82%
1 Year
+44.10%
3 Years
+15.60%
5 Years
-2.83%
10 Years
+10.43%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would XBI have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+2.14%

3 Months Performance

+3.79%

6 Months Performance

+42.27%

1 Year Performance

+44.10%

Benchmark & Peers

Benchmark
S&P Biotechnology Select Industry Index(^SPSIBI:SP)
This ETF (YTD)
+4.82%
Peer Avg (YTD)
+1.55%
vs Peers
+3.27%

XBI ETF Performance

XBI performance across multiple time periods: 1-month 2.14%, YTD 4.82%, 1-year 44.10%, 3-year 15.60%, 5-year -2.83%, 10-year 10.43%.

XBI returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.35%, investors should weigh costs against performance when evaluating this ETF.

XBI performance comparison shows side-by-side returns with another fund. XBI alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+2.14%N/A
3 Months+3.79%N/A
6 Months+42.27%N/A
1 Year+44.10%N/A
3 Years+15.60%N/A
5 Years-2.83%N/A

All returns shown are total returns, not annualized